Why Weight? An Analytic Review of Obesity Management, Diabetes Prevention, and Cardiovascular Risk Reduction

L. I. Igel, K. H. Saunders, J. J. Fins

Research output: Contribution to journalReview article

8 Scopus citations

Abstract

Purpose of Review: In this review, we examine one of the ironies of American health care—that we pay more for disease management than disease prevention. Instead of preventing type 2 diabetes (T2DM) by treating its precursor, obesity, we fail to provide sufficient insurance coverage for weight management only to fund the more costly burden of overt T2DM. Recent Findings: There is a vital need for expanded insurance coverage to help foster a weight-centric approach to T2DM management. This includes broader coverage of anti-diabetic medications with evidence of cardiovascular risk reduction and mortality benefit, anti-obesity pharmacotherapy, bariatric surgery, weight loss devices, endoscopic bariatric therapies, and lifestyle interventions for the treatment of obesity. Summary: The fundamental question to ask is why weight? Why wait to go after obesity until its end-stage sequelae cause intractable conditions? Instead of managing the complications of T2DM, consider preventing them by tackling obesity.

Original languageEnglish (US)
Article number39
JournalCurrent Atherosclerosis Reports
Volume20
Issue number8
DOIs
StatePublished - Aug 1 2018

Keywords

  • Access to care
  • Diabetes prevention
  • Evidence-based medicine
  • Insurance coverage
  • Obesity treatment
  • Type 2 diabetes mellitus

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Why Weight? An Analytic Review of Obesity Management, Diabetes Prevention, and Cardiovascular Risk Reduction'. Together they form a unique fingerprint.

Cite this